The new 3.3 gigawatt (GW)DC facility, which is scheduled to commence operations in the first half of 2023, represents a $680 million investment. When fully operational, the facility is expected to scale the company’s Northwest Ohio footprint to a total annual capacity of 6 GWDC, which is believed to make it the largest fully vertically integrated solar manufacturing complex outside China.
Exyte, a global leader in the design, engineering, and delivery of facilities for high-tech industries, has collaborated with Morrow Batteries (“Morrow”) in the development of integrated production concepts for their new state-of-the-art Lithium-Ion battery production site in Norway.
NASA and Boeing have decided to postpone the launch of Orbital Flight Test-2 to the International Space Station as teams continue work on the CST-100 Starliner propulsion system.
SK hynix has grown into one of the leading chipmakers in the world through continuous effort to secure a fundamental competitive edge in the fierce semiconductor industry. With the emergence of new entrants and the consolidation of incumbent players, the competition and technological barriers are continuously heightening in the market.
Almac has manufactured multiple High Throughput batches of neoantigen derived peptides –branded by Almac as NeoPeptides™ – for compassionate use treatments, and for P-I clinical trials, from its Edinburgh facility. Over the course of the past ten months the facility has been upgraded and segregated to enable GMP supply.
Perovskite solar cells are currently electrifying the solar cell community. This new, cheap, and easy-to-process material has almost ideal physical properties for converting light into electricity: as it is pitch-black, a very thin layer of less than a thousandth of a millimeter is sufficient to absorb all incident sunlight.
Biosensors are devices that can detect biological molecules in air, water, or blood. They are widely used in drug development, medical diagnostics, and biological research. The growing need for continuous, real-time monitoring of biomarkers in diseases like diabetes is currently driving efforts to develop efficient and portable biosensor devices.
Scientists from Higher school of economics and the Federal Scientific Research Centre ‘Crystallography and Photonics’ have synthesized multi-layered nanowires in order to study their magnetoresistance properties.
The Brock team’s latest technology builds on an earlier version of the microscopic robot — called the three-dimensional DNA nanomachine — they created in 2016 to detect diseases in a blood sample within 30 minutes.
SignalFire Wireless Telemetry introduces the ModQ Sentry, a Modbus Flow Totalizer that interfaces with pulse-type inductive turbine (and other) flow meters to provide instantaneous flow rates, accumulated totals and status information. Units are configurable for volume and time settings and offer options to configure the K factor to match the turbine.
Private equity firm Graham Partners has entered injection molded medical goods with an investment in Medbio LLC of Grand Rapids, Mich. Graham Partners acquired a majority interest in Medbio, effective July 18 for undisclosed terms, according to Graham managing principal Joe Heinmiller.
The creation of artificial embryos has moved a step forward after an international team of researchers used mouse stem cells to produce artificial embryo-like structures capable of ‘gastrulation’, a key step in the life of any embryo.